#32026R0398Commission Implementing Regulation (EU) 2026/398 amending Implementing Regulation (EU) No 686/2012 as regards the allocation of rapporteur Member States for metconazole and quinolin-8-ol
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This regulation allocates rapporteur and co-rapporteur Member States for the renewal evaluation of two active substances used in plant protection products. Sweden is designated as rapporteur for metconazole with Belgium as co-rapporteur. The Netherlands is designated as rapporteur for quinolin-8-ol, again with Belgium as co-rapporteur. These allocations are added to Part E of the Annex of Implementing Regulation (EU) No 686/2012. The purpose is to ensure balanced distribution of evaluation responsibilities among Member States for substances whose approvals were recently renewed until 2031 and 2032 respectively.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Allocates Sweden (SE) as rapporteur Member State and Belgium (BE) as co-rapporteur for metconazole
- Allocates Netherlands (NL) as rapporteur Member State and Belgium (BE) as co-rapporteur for quinolin-8-ol
- Inserts new entries into Part E of the Annex to Implementing Regulation (EU) No 686/2012
+ 3 more changes with Pro
Obligations
What this law requires
Sweden must serve as rapporteur Member State for the renewal evaluation of metconazole active substance
Belgium must serve as co-rapporteur Member State for the renewal evaluation of metconazole active substance
The Netherlands must serve as rapporteur Member State for the renewal evaluation of quinolin-8-ol active substance
Belgium must serve as co-rapporteur Member State for the renewal evaluation of quinolin-8-ol active substance
Amend Part E of the Annex to Implementing Regulation (EU) No 686/2012 to include the allocation entry for metconazole (SE as rapporteur, BE as co-rapporteur)